These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11740407)

  • 1. New drugs: the way forward.
    Gazzard BG
    J HIV Ther; 2001 Nov; 6(4):73-6. PubMed ID: 11740407
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment interruption: study found poor result for highly treated, highly resistant patients.
    James JS
    AIDS Treat News; 2003 Sep; (394):7-8. PubMed ID: 14669730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interruptions may be beneficial.
    AIDS Patient Care STDS; 2002 Oct; 16(10):512. PubMed ID: 12442736
    [No Abstract]   [Full Text] [Related]  

  • 4. CD4 cell count-guided treatment interruption: be smart and wait for more evidence.
    Arduino R
    Clin Infect Dis; 2005 Mar; 40(5):735-7. PubMed ID: 15714421
    [No Abstract]   [Full Text] [Related]  

  • 5. A guide for understanding the guidelines.
    Sharp M
    Posit Aware; 2004; 15(1):43-5. PubMed ID: 14989197
    [No Abstract]   [Full Text] [Related]  

  • 6. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
    Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
    Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
    Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
    J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 9. New viral fitness test helps determine regimens.
    AIDS Alert; 2002 Aug; 17(8):100-1. PubMed ID: 12647689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection.
    de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V
    J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral suppression of HIV in the context of persistently low CD4 counts: new insights.
    Laurence J
    AIDS Read; 2007 Jan; 17(1):7, 18. PubMed ID: 17274141
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
    Nuesch R; Ananworanich J; Sirivichayakul S; Ubolyam S; Siangphoe U; Hill A; Cooper D; Lange J; Phanuphak P; Ruxrungtham K
    Clin Infect Dis; 2005 Mar; 40(5):728-34. PubMed ID: 15714420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The more things change..
    Zuniga JM
    IAPAC Mon; 2005 Mar; 11(3):60-1. PubMed ID: 16110533
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.
    Jaafar A; Massip P; Sandres-Sauné K; Souyris C; Pasquier C; Aquilina C; Izopet J
    J Med Virol; 2004 Sep; 74(1):8-15. PubMed ID: 15258962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactions to the New York "supervirus". A challenge in primary resistance].
    Paukstadt W
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():86. PubMed ID: 16385890
    [No Abstract]   [Full Text] [Related]  

  • 16. Treating HIV is rarely an emergency. An interview with Joseph Sonnabend. Interview by Bob Huff.
    Sonnabend J
    GMHC Treat Issues; 2005; 19(9-11):10-5. PubMed ID: 16541506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs in the fight against HIV disease.
    Rosenthal E
    HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of antiretroviral HIV treatment success based on medical history or guided by the reverse hybridisation LiPA HIV genotyping system.
    Alvarez M; García F; Martínez NM; Hernández Quero J; Louwagie J; De Brauwer A; Maroto MC
    J Med Virol; 2004 Jun; 73(2):151-7. PubMed ID: 15122786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.